FOLH1 and prostate carcinoma: In this work, we developed a nanoparticle-based tool with contemporary fluorescent silica nanoparticles decorated with antibodies against prostate-specific membrane antigen (PSMA), highly expressed in prostate cancer cells and MMAE.